|
|
Article: Activated Cell Therapy introduces SimpleSep high yield CD34 enrichment kit.
- Article from:
- Business Wire
- Article date:
- December 1, 1994
CopyrightCOPYRIGHT 1994 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Dec. 1, 1994--Activated Cell Therapy Inc. (ACT) will introduce the SimpleSep High Yield CD34 Enrichment Kit at the American Society of Hematology (ASH) Convention in Nashville, Dec. 3-5.
SimpleSep is an easy-to-use research kit that is the first step in cell enrichment. The first commercial product from ACT, SimpleSep is a versatile and cost efficient device which produces a high yield of viable CD34 cells.
SimpleSep is a user-friendly system that offers significant advantages in cell recovery. This three-step technique requires no special training, no pipetting for cell recovery, and can be completed in ...
Related newspaper, magazine, and journal articles:
|
|
Article: BioTransplant signs agreement with Activated Cell ...
Transplant News;
September 17, 1996 ;
700+ words
...BioTransplant, Inc., Charlestown, MA, and Activated Cell Therapy (ACT), Mountain View, CA, signed an agreement ... 617) 241-5200; or Richard Bastiani, PhD, Activated Cell Therapy - (415) 964-6744
|
|